Zacks Investment Research
12 Jan 2026, 13:46 UTC · 40w ago
Neogen's Q2 Earnings and Revenues Beat Estimates, Stock Climbs
Impact · against what's priced in
Neogen's stock surged 31.6% following an earnings and revenue beat, indicating the market was previously discounting the company's near-term performance. However, the jump is tempered by deteriorating operational efficiency, evidenced by a swing to an operating loss of $5.4 million.
- NEOG+0.40
No priced-in read yet
- In context
The company beat EPS estimates by 42.86% and revenue estimates by 7.93%, triggering a 31.6% price jump, though an operating loss of $5.4 million suggests underlying margin pressure.
Read from the article alone
